// App-Quantinova.ai

1090 : FCGR3A V/F 158 Polymorphism Is Not Associated with Response to Rituximab in adul-s Immune Thrombocytopenia

Researchers

Presenter

  • France Noizat-Pirenne

Principal Investigators

  • Christophe Tournamille

  • Olivier Fain

  • Jean-Francois Viallard

  • Bertrand Godeau

  • Marc Michel

Medical Centers

  • Etablissement Francais du Sang, site Henri Mondor, Creteil, France

  • Centre Hospitalier Universitaire Henri Mondor, Creteil, France

  • Internal medicine department, Hopital du Haut Leveque - University of Bordeaux, Pessac, France

  • site EFS Henri Mondor, Creteil, France

  • Internal Medicine, Henri Mondor University Hospital, Universite Paris-Est, Creteil, France

  • internal medicine, Hopital Jean Verdier, AP-HP, Bondy, FL, France

  • Department of Internal Medicine, EFS U EQ, Henri Mondor Hospital, Assistance Publique Hopitaux de Paris, Paris Est Creteil university, Creteil, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Immune thrombocytopenia

  • Rheumatoid arthritis

  • Thrombocytopenia

  • Hepatitis C

  • Inflammatory Arthritis

Biomarkers

  • Fc gamma RIIIa

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Hydroxychloroquine

  • Mycophenolic acid

  • Eltrombopag

  • Vinblastine

  • Vincristine

  • Rituximab

  • Danazol

  • Dapsone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved